Sharesight users' top 20 ASX trades of FY23/24

Welcome to our annual Australian financial year trading snapshot, where we look at the 20 most traded ASX stocks by Sharesight users during the 2023/24 financial year. To find out the market-moving news behind some of these stocks, keep reading.

In this FY23/24 trading snapshot, trades were strongly led by Vanguard’s Australian Shares Index ETF (ASX: VAS). In terms of individual stocks, trades were led by Woodside Energy (ASX: WDS), which posted declining earnings throughout the financial year. This was reflected in its share price, which has been on a steep downward trend since October 2023. The top trades were followed by BHP (ASX: BHP), which also posted a number of disappointing earnings results. Despite this, the miner’s share price remained relatively stable throughout the financial year. Overall, the top trades for FY23/24 were heavily weighted towards index-tracking ETFs and blue chip stocks in the mining and banking sectors.

Woodside Energy (ASX: WDS)

• July 2023: Q2 revenue down almost 30% compared to Q1, fuelled by lower global commodity prices
• August 2023: Woodside approved to develop Mexico’s Trion deepwater oil project; share price rises
• October 2023: Misses Q3 revenue estimate, narrows full-year production outlook
• November 2023: Woodside blames poor customer uptake for slow progress on clean energy goals
• December 2023: Woodside in preliminary talks with Santos over proposed merger
• January 2024: Woodside and Exxon pledge to supply gas to east coast market amid shortfall fears
• February 2024: Woodside share price rises despite 74% drop in FY23 profit
• March 2024: Woodside denounced for lack of action on climate and clean energy
• May 2024: Share price has plummeted 17% in six months
• June 2024: Woodside restructures management team to prepare for energy transition

BHP (ASX: BHP)

• July 2023: BHP posts iron ore record but warns of uncertainty ahead to due to inflation and global economic volatility
• August 2023: BHP profit drops 37%, fuelled by Chinese economic woes
• September 2023: BHP receives council approval for 1,100-bed mining camp in Kalgoorlie-Boulder
• October 2023: BHP says “same job same pay” reforms would make it “unfeasible” to achieve diversity targets
• November 2023: BHP share price up 10% in a month
• December 2023: Share price plummets following BHPs decision not to acquire Broken Hill copper project
• January 2024: BHP share price drops following lacklustre Q2 results
• February 2024: Announces 86% drop in half-year profit
• March 2024: BHP cuts 25% of WA nickel project workforce
• April 2024: BHP and Mitsubishi complete AU$4.1 billion sale of Queensland coal mines
• May 2024: Brokers are bullish on BHP following quarterly results
• June 2024: Share price drops following decarbonisation update

Pilbara Minerals (ASX: PLS)

• July 2023: Pilbara CEO dismisses plummeting share prices as disproportionate response to drop in lithium prices
• August 2023: Pilbara shares down despite profit growth
• September 2023: Pilbara Minerals now the most shorted stock on the ASX; lithium stocks increasingly targeted
• October 2023: Falls short of market expectations in Q1 earnings results
• November 2023: Share price has dropped 26% over the past six months
• December 2023: Pilbara short-selling hits a new high as analysts divided over stock’s future
• January 2024: Pilbara share price drops despite news of expanded offtake agreement with Ganfeng Lithium
• February 2024: Shares plummet as Pilbara reports 76% drop in half-year profit, plans to withhold dividend
• March 2024: Pilbara share price rises on deal with Tesla supplier
• May 2024: Leading broker expects Pilbara share price to fall 35% over the next year

ResMed (ASX: RMD)

• August 2023: ResMed revenue grows 23% YoY to AU$1.1 billion
• September 2023: ResMed shares hit new 52-week low
• October 2023: ResMed reports 16% revenue growth for Q1 FY24
• December 2023: Share price rises following patent victory against NYU
• April 2024: ResMed share price dives on positive news about weight loss drug trials
• June 2024: Share price nosedives due to Ozempic-related sell-off; investors rush to buy the dip

CSL (ASX: CSL)

• July 2023: CSL share price hits new 52-week low
• August 2023: CSL share price could come under pressure as new competitor enters the market
• September 2023: CSL pens deal with UK government to produce flu vaccines
• October 2023: CSL share price hits multi-year low
• December 2023: Unions urge super funds to drop CSL shares
• April 2024: CSL share price falls despite FDA approval of kidney disease treatment

Macquarie Group (ASX: MQG)

• September 2023: Shares drop due to concerns over economic headwinds for asset management branch
• November 2023: Macquarie cuts jobs as tech expenses grow
• January 2024: Macquarie raises AU$8.72 billion for new European infrastructure fund
• February 2024: Macquarie profit plummets due to weakness in commodities and global markets business; commodities head to step down
• May 2024: Share price drops following disappointing FY24 earnings

Fortescue Metals (ASX: FMG)

• July 2023: Reports record iron ore shipments of 192Mt for FY23; forecasts rise in shipments for FY24
• August 2023: Reveals 23% profit decline in FY23 earnings results
• September 2023: Fortescue CEO and CFO step down
• November 2023: Fortescue share price hits two-year high
• January 2024: Fortescue founder shuts WA nickel mines bought for AU$760 million just six months ago
• March 2024: Fortescue attributes senior executive exodus to ‘cultural misalignment’
• June 2024: Share price plummets as AU$1.1 billion stake hits the market

Track your investment portfolio with Sharesight

Get access to Sharesight20 insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you:

• Track all your investments in one place, including stocks, mutual/managed funds, property, and even cryptocurrency
• Get the true picture of your investment performance, including the impact of brokerage fees, dividends, and capital gains with Sharesight’s annualised performance calculation methodology
• Run powerful reports built for investors, including performance, portfolio diversity, contribution analysis, multi-currency valuation, multi-period, exposure and future income (upcoming dividends)
• Run tax reports including taxable income (dividends/distributions), capital gains tax (Australia and Canada), Traders Tax (Capital Gains for traders in NZ) and FIF foreign investment fund income reports (NZ)

Sign up for a FREE Sharesight account and get started tracking your investments today.

Disclaimer: The above article is for informational purposes only and does not constitute a specific product recommendation, or taxation or financial advice and should not be relied upon as such. While we use reasonable endeavours to keep the information up-to-date, we make no representation that any information is accurate or up-to-date. If you choose to make use of the content in this article, you do so at your own risk. To the extent permitted by law, we do not assume any responsibility or liability arising from or connected with your use or reliance on the content on our site. Please check with your adviser or accountant to obtain the correct advice for your situation.

FURTHER READING

• EOFY checklist for Australian investors
• Capital gains tax calculator for Australian investors
• 5 ways Sharesight helps Australian investors at tax time